Loading RXRX charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading RXRX comparable companies…
| RXRXRecursion Pharmaceuticals, Inc.(opens in a new tab) | $2.14B | $0.05B | −15.1% | 3.5% | −991.7% | 39.07× | — |
|---|---|---|---|---|---|---|---|
| IVVDInvivyd, Inc.(opens in a new tab) | $0.19B | $0.06B | +26.3% | — | −192.8% | 3.21× | — |
| CHRSCoherus Oncology, Inc.(opens in a new tab) | $0.13B | $0.05B | +61.0% | 68.9% | −311.6% | 2.53× | — |
| FENCFennec Pharmaceuticals Inc.(opens in a new tab) | $0.37B | $0.06B | +77.8% | 94.1% | −1.9% | 6.26× | — |
| CSBRChampions Oncology, Inc.(opens in a new tab) | — | $0.06B | +6.7% | 49.8% | −1.7% | — | — |
| Medianpeers, excl. RXRX | $0.19B | $0.06B | +43.7% | 68.9% | −97.4% | 3.21× | — |